OTCMKTS:TRPXY

Therapix Biosciences (TRPXY) Stock Price, News & Analysis

$6.03
+0.03 (+0.50%)
(As of 02/9/2021)
Today's Range
$6.00
$6.15
50-Day Range
$6.03
$6.03
52-Week Range
$2.75
$22.40
Volume
53,500 shs
Average Volume
12,316 shs
Market Capitalization
$6.25 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

About Therapix Biosciences

Therapix Biosciences Ltd., a specialty clinical-stage pharmaceutical company, develops drugs based on cannabinoid molecules. Its drug development programs include THX-110, which has completed Phase II a clinical trial for the treatment of Tourette syndrome and Obstructive Sleep Apnea; THX-160, which has completed two preliminary preclinical studies for the treatment of acute and chronic pain; and THX-210 for the treatment of autism spectrum disorder and epilepsy. Therapix Biosciences Ltd. has a collaboration with The University of Calgary to evaluate the analgesic effect of Therapix's CB2R agonist proprietary drug candidate, THX-160. The company was formerly known as NasVax Ltd. and changed its name to Therapix Biosciences Ltd. in November 2013. Therapix Biosciences Ltd. was founded in 2004 and is headquartered in Givatayim, Israel.

TRPXY Stock Price History

TRPXY Stock News Headlines

No headlines for this company have been tracked by MarketBeat.com
Receive TRPXY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Therapix Biosciences and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
OTCMKTS:TRPXY
CIK
N/A
Fax
N/A
Employees
8
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Market Cap
$6.25 million
Optionable
Not Optionable
Beta
N/A
7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed Investors Cover

As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.

Get This Free Report

TRPXY Stock Analysis - Frequently Asked Questions

How have TRPXY shares performed in 2024?

Therapix Biosciences' stock was trading at $6.03 at the beginning of 2024. Since then, TRPXY stock has increased by 0.0% and is now trading at $6.03.
View the best growth stocks for 2024 here
.

How do I buy shares of Therapix Biosciences?

Shares of TRPXY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:TRPXY) was last updated on 4/24/2024 by MarketBeat.com Staff

From Our Partners